[Topical intranasal cortisone therapy].

Recenti Prog Med

Istituto di Clinica otorinolaringoiatrica, Università cattolica del Sacro Cuore, Roma.

Published: April 1991

Owing to improvements made during the last 15 years in the pathophysiological and pharmacological research, many new corticosteroids have been successfully experimented. They have high activity on the target organ and they are suitable for long term therapies since they have not any systemic and/or local side effects. Nowadays the topical intranasal corticosteroid therapy is indispensable for allergic rhinitis treatment and it is very useful for many nasal and bronchopulmonary diseases (some chronic rhinitis, nasal polyposis, bronchial asthma, chronic obstructive bronchopulmonary diseases). The authors use their personal experience and carefully review the literature to describe the general aspects (pharmacology, pharmacokinetics, toxicology, side effects and contraindications) and to analyze the single drugs currently used in Italy and abroad. Finally, they compare the efficacy of each topical intranasal glucocorticoid among themselves and with other drugs.

Download full-text PDF

Source

Publication Analysis

Top Keywords

side effects
8
topical intranasal
8
bronchopulmonary diseases
8
[topical intranasal
4
intranasal cortisone
4
cortisone therapy]
4
therapy] improvements
4
improvements years
4
years pathophysiological
4
pathophysiological pharmacological
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!